Pitlik; Janos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pitlik; Janos.The latest application filed is for "inhibitors of serine proteases, particularly hcv ns3-ns4a protease".

Company Profile

1.20.24

Pitlik; Janos - Westborough MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,691,758 - Britt , et al. April 8, 2	2014-04-08
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20140031277 - Cottrell; Kevin M. ; et al.	2014-01-30
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20140010784 - Farmer; Luc J. ; et al.	2014-01-09
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20130316945 - Cottrell; Kevin M. ; et al.	2013-11-28
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,536,136 - Deininger , et al. September 17, 2	2013-09-17
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,486,989 - Farmer , et al. July 16, 2	2013-07-16
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20130116169 - Perni; Robert B. ; et al.	2013-05-09
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,426,359 - Cottrell , et al. April 23, 2	2013-04-23
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,217,048 - Perni , et al. July 10, 2	2012-07-10
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 8,039,623 - Cottrell , et al. October 18, 2	2011-10-18
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20110104115 - Perni; Robert B. ; et al.	2011-05-05
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,906,550 - Cottrell , et al. March 15, 2	2011-03-15
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20100330109 - Cottrell; Kevin M. ; et al.	2010-12-30
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20100173851 - Pitlik; Janos ; et al.	2010-07-08
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,745,444 - Perni , et al. June 29, 2	2010-06-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,683,033 - Cottrell , et al. March 23, 2	2010-03-23
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20090291902 - Cottrell; Kevin M. ; et al.	2009-11-26
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20080311079 - Perni; Robert B. ; et al.	2008-12-18
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease App 20080125376 - Cottrell; Kevin M. ; et al.	2008-05-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,378,422 - Perni , et al. May 27, 2	2008-05-27
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,365,092 - Cottrell , et al. April 29, 2	2008-04-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20080045480 - Farmer; Luc J. ; et al.	2008-02-21
Inhibitors of serine proteases, particular HCV NS3-NS4A protease App 20070292933 - Pitlik; Janos ; et al.	2007-12-20
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,273,885 - Pitlik , et al. September 25, 2	2007-09-25
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20070161789 - Cottrell; Kevin M. ; et al.	2007-07-12
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,241,796 - Farmer , et al. July 10, 2	2007-07-10
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases Grant 7,208,600 - Cottrell , et al. April 24, 2	2007-04-24
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20060211629 - Britt; Shawn D. ; et al.	2006-09-21
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Grant 7,109,172 - Britt , et al. September 19, 2	2006-09-19
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050215486 - Cottrell, Kevin ; et al.	2005-09-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050137139 - Perni, Robert B. ; et al.	2005-06-23
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases App 20050137140 - Cottrell, Kevin M. ; et al.	2005-06-23
Bridged bicyclic serine protease inhibitors Grant 6,909,000 - Farmer , et al. June 21, 2	2005-06-21
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050119189 - Cottrell, Kevin M. ; et al.	2005-06-02
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20050107304 - Britt, Shawn D. ; et al.	2005-05-19
Inhibitors of serine proteases, particularly HVC NS3-NS4A protease App 20050080017 - Cottrell, Kevin M. ; et al.	2005-04-14
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20040018986 - Pitlik, Janos ; et al.	2004-01-29
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease App 20030134889 - Farmer, Luc J. ; et al.	2003-07-17
Bridged bicyclic serine protease inhibitors App 20030119752 - Farmer, Luc J. ; et al.	2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.